Form D — Auron Therapeutics, Inc.
0001746139-26-000002 · filed Aug 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $12,000,000
- Reported amount sold
- $7,118,141
- Minimum investment
- $0
- Investors
- 14
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Auron Therapeutics, Inc.
- CIK
- 1746139
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1 Grove Street
Wellesley, Massachusetts 02482-9998 - Phone
- 310-922-5881
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Katharine Yen · Executive OfficerWellesley, Massachusetts Find on LinkedIn ↗
-
Alexandra Cantley · DirectorWellesley, Massachusetts Find on LinkedIn ↗
-
Briggs Duncan Morrison · DirectorWellesley, Massachusetts Find on LinkedIn ↗
-
Anna French · DirectorWellesley, Massachusetts Find on LinkedIn ↗
-
Pini Orbach · DirectorWellesley, Massachusetts Find on LinkedIn ↗
-
Serge Messerlian · DirectorWellesley, Massachusetts Find on LinkedIn ↗
-
Victoria Richon · DirectorWellesley, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗